hich dogs with appendicular osteosarcoma benefit most from hemotherapy after surgery ? Results from an individual patient data eta-analysis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions.

  2015cited by this paper
• Using Internally Developed Risk Models to Assess Heterogeneity in Treatment Effects in Clinical Trials

  2014cited by this paper
• Appendicular osteosarcoma in small-breed dogs: 51 cases (1986-2011).

  2014cited by this paper
• Risk prediction models.

  2013cited by this paper
• Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis.

  2013cited by this paper
• Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.

  2013cited by this paper
• Prognostic factors in canine appendicular osteosarcoma – a meta-analysis

  2012cited by this paper
• The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review

  2011cited by this paper
• Logistic regression modeling and the number of events per variable: selection bias dominates.

  2011cited by this paper
• Conducting Meta-Analyses in R with the metafor Package

  2010influential reference
• Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures

  2010cited by this paper
• Association of blood monocyte and lymphocyte count and disease-free interval in dogs with osteosarcoma.

  2010cited by this paper
• Bmc Medical Research Methodology Open Access Combining Estimates of Interest in Prognostic Modelling Studies after Multiple Imputation: Current Practice and Guidelines

  2009cited by this paper
• Clinical Prediction Models—a Practical Approach to Development, Validation and Updating

  2009cited by this paper
• Impact of telomerase status on canine osteosarcoma patients.

  2008cited by this paper
• Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk Score

  2008cited by this paper
• Characterization of the biological behaviour of appendicular osteosarcoma in Rottweilers and a comparison with other breeds: a review of 258 dogs.

  2007cited by this paper
• Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

  2007cited by this paper
• Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.

  2005cited by this paper
• Missing data

  2004cited by this paper
• Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.

  2003cited by this paper
• Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

  2002cited by this paper
• STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

  2002cited by this paper
• Confidence Intervals for the Predictions of Logistic Regression in the Presence and Absence of a Variance- Covariance Matrix

  2002cited by this paper
• Prognostic Significance of a New Histologic Grading System for Canine Osteosarcoma

  2002cited by this paper
• Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians.

  2000cited by this paper
• Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: a pilot study.

  2000cited by this paper
• Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis.

  1999cited by this paper
• Host related risk factors for canine osteosarcoma.

  1998cited by this paper
• Skeletal neoplasms of small dogs: a retrospective study and literature review.

  1997cited by this paper
• Limb-sparing surgery versus amputation for dogs with bone tumors.

  1996cited by this paper
• Canine osteosarcoma: amputation and chemoimmunotherapy.

  1996cited by this paper
• Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.

  1995cited by this paper
• Model uncertainty, data mining and statistical inference

  1995cited by this paper
• Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988).

  1992cited by this paper
• Amputation and cisplatin for treatment of canine osteosarcoma.

  1991cited by this paper
• Publication bias in clinical research.

  1991cited by this paper
• Characterization of osteosarcoma cells from two sibling large-breed dogs.

  1989cited by this paper
• Results of surgical treatment in 65 dogs with osteosarcoma.

  1976influential reference
• INFERENCE AND MISSING DATA

  1975cited by this paper

• No citing papers are available for this paper.